Literature DB >> 16122182

Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia.

R L M Bekkers1, I A M van der Avoort, W J G Melchers, J Bulten, P C M de Wilde, L F A G Massuger.   

Abstract

PURPOSE: To study the alterations in hormonal sensitivity in relation to proliferative activity during the development of cervical dysplasia in women infected with high-risk human papillomavirus (hr-HPV).
METHODS: Three to five biopsies of the cervix of eight patients were taken at colposcopy. Dysplasia was detected in 22 of the 32 biopsies, and 20 of these 22 biopsies contained hr-HPV. The labeling index (LI) as well as the intensity of staining of the MIB-1-, estrogen receptor (ER)-, and progesterone receptor (PR)-expression was assessed in each biopsy, including normal epithelium directly adjacent to the dysplastic lesions.
RESULTS: Statistical analysis showed a significant increase in the MIB-1 LI with increasing severity of the dysplasia. The ER LI and ER intensity of staining in dysplastic lesions, as well as in morphologically normal epithelium directly adjacent to the dysplasia, showed a significant inverse relation with the severity of the dysplasia. The PR LI and intensity of staining did not differ between normal epithelium and dysplasia. The ER/MIB-1 ratio (including the ER LI and ER intensity of staining), and the PR/MIB-1 ratio (intensity of staining only) in dysplastic lesions showed a significant inverse relation with the severity of the dysplasia, while no alterations in these ratios were observed in morphologically normal epithelium adjacent to the dysplasia.
CONCLUSION: Down regulation of ER expression may be the first alteration to take place in normal epithelium during the development of cervical dysplasia in women infected with hr-HPV. The significant decrease in the ER/MIB-1-, and PR/MIB-1-ratio in progressively dysplastic lesions indicates a loss of normal growth control by sex steroid hormones, which is not observed in normal epithelium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122182

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  5 in total

1.  Loss of estrogen receptor 1 enhances cervical cancer invasion.

Authors:  Yali Zhai; Guido T Bommer; Ying Feng; Alexandra B Wiese; Eric R Fearon; Kathleen R Cho
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

2.  Ciliated/tubal-type in-situ and invasive endocervical adenocarcinoma: Report of three cases with limited follow-up and review of the literature.

Authors:  Shivali Marketkar; Joyce Ou; C James Sung; M Ruhul Quddus
Journal:  Gynecol Oncol Rep       Date:  2022-06-23

3.  The cervical malignant cells display a down regulation of ER-α but retain the ER-β expression.

Authors:  Ricardo López-Romero; Efraín Garrido-Guerrero; Angélica Rangel-López; Leticia Manuel-Apolinar; Patricia Piña-Sánchez; Minerva Lazos-Ochoa; Alejandra Mantilla-Morales; Cindy Bandala; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

4.  Expression of hormone receptors in oropharyngeal squamous cell carcinoma.

Authors:  Hesham Mohamed; Katri Aro; Lauri Jouhi; Antti Mäkitie; Satu Remes; Caj Haglund; Timo Atula; Jaana Hagström
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-26       Impact factor: 2.503

5.  Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.

Authors:  F E Henken; S M Wilting; R M Overmeer; J G I van Rietschoten; A O H Nygren; A Errami; J P Schouten; C J L M Meijer; P J F Snijders; R D M Steenbergen
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.